Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT.
Harding C, Chadwick T, Homer T, Lecouturier J, Mossop H, Carnell S, King W, Abouhajar A, Vale L, Watson G, Forbes R, Currer S, Pickard R, Eardley I, Pearce I, Thiruchelvam N, Guerrero K, Walton K, Hussain Z, Lazarowicz H, Ali A. Harding C, et al. Among authors: pearce i. Health Technol Assess. 2022 May;26(23):1-172. doi: 10.3310/QOIZ6538. Health Technol Assess. 2022. PMID: 35535708 Free article. Clinical Trial.
ALternatives To prophylactic Antibiotics for the treatment of Recurrent urinary tract infection in women (ALTAR): study protocol for a multicentre, pragmatic, patient-randomised, non-inferiority trial.
Forbes R, Ali A, Abouhajar A, Brennand C, Brown H, Carnell S, Chadwick T, Eardley I, Lecouturier J, Mossop H, Pearce I, Pickard R, Thiruchelvam N, Walton K, Wilkinson J, Harding C. Forbes R, et al. Among authors: pearce i. Trials. 2018 Nov 9;19(1):616. doi: 10.1186/s13063-018-2998-4. Trials. 2018. PMID: 30413181 Free PMC article.
Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trial.
Harding C, Mossop H, Homer T, Chadwick T, King W, Carnell S, Lecouturier J, Abouhajar A, Vale L, Watson G, Forbes R, Currer S, Pickard R, Eardley I, Pearce I, Thiruchelvam N, Guerrero K, Walton K, Hussain Z, Lazarowicz H, Ali A. Harding C, et al. Among authors: pearce i. BMJ. 2022 Mar 9;376:e068229. doi: 10.1136/bmj-2021-0068229. BMJ. 2022. PMID: 35264408 Free PMC article. Clinical Trial.
Nomogram predicting the probability of spontaneous stone passage in patients presenting with acute ureteric colic.
Gao C, Peters M, Kurver P, Anbarasan T, Jayaraajan K, Manning T, Cashman S, Nambiar A, Cumberbatch M, Lamb BW, Pickard R, Erotocritou P, Smith D, Kasivisvanathan V, Shah TT; BURST Collaborative MIMIC Study Group. Gao C, et al. BJU Int. 2022 Jun 28;130(6):823-31. doi: 10.1111/bju.15839. Online ahead of print. BJU Int. 2022. PMID: 35762278 Free PMC article.
Adalimumab for non-infectious uveitis: is it cost-effective?
Bermejo I, Squires H, Poku EN, Cooper K, Stevens JW, Hamilton J, Wong R, Pearce I, Quhill FM, Denniston AK. Bermejo I, et al. Among authors: pearce i. Br J Ophthalmol. 2019 Nov;103(11):1633-1638. doi: 10.1136/bjophthalmol-2018-312756. Epub 2019 Feb 6. Br J Ophthalmol. 2019. PMID: 30728124 Free article.
Dexamethasone implant for non-infectious uveitis: is it cost-effective?
Squires H, Bermejo I, Poku EN, Cooper K, Stevens J, Hamilton J, Wong R, Denniston AK, Pearce I, Quhill FM. Squires H, et al. Among authors: pearce i. Br J Ophthalmol. 2019 Nov;103(11):1639-1644. doi: 10.1136/bjophthalmol-2018-312765. Epub 2019 Feb 11. Br J Ophthalmol. 2019. PMID: 30745307 Free article.
Internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole: a pragmatic randomized controlled trial.
Lois N, Burr J, Norrie J, Vale L, Cook J, McDonald A, Boachie C, Ternent L, McPherson G; Full-thickness Macular Hole and Internal Limiting Membrane Peeling Study (FILMS) Group. Lois N, et al. Invest Ophthalmol Vis Sci. 2011 Mar 1;52(3):1586-92. doi: 10.1167/iovs.10-6287. Invest Ophthalmol Vis Sci. 2011. PMID: 21051731 Clinical Trial.
205 results